Clinical Trial Update: Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 biosimilarity study evaluating subcutaneous pegfilgrastim in healthy volunteers to assess pharmacokinetic/pharmacodynamic similarity for neutropenia man…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Megalabs | Conditions: Neutropenia | Phase 1 | Status: COMPLETED